Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | BCL9 | O00512 | 1/20 | 0.46 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.44 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6277355 | 0.85 | HTR2A (0.53) | HTR2ABCL9CTNNB1MAPTALDH1A1 | |
| SCHEMBL6394617 | 0.82 | HTR2A (0.52) | HTR2ABCL9CTNNB1MAPTALDH1A1 | |
| SCHEMBL6395093 | 0.81 | HTR2A (0.62) | HTR2AMAPTALDH1A1KDM4EGAA | |
| SCHEMBL1714950 | 0.79 | HTR2A (0.70) | HTR2ABCL9CTNNB1MAPTALDH1A1 | |
| SCHEMBL6652016 | 0.78 | HTR2A (0.55) | HTR2ABCL9CTNNB1MAPTALDH1A1 | |
| SCHEMBL7463242 | 0.78 | HTR2A (0.58) | HTR2ABCL9CTNNB1MAPTALDH1A1 | |
| SCHEMBL6648115 | 0.78 | PTPN7 (0.57) | HTR2ABCL9CTNNB1MAPTALDH1A1 | |
| SCHEMBL14277073 | 0.78 | EPHX1 (0.56) | HTR2AALDH1A1KDM4EGAAMEN1 | |
| SCHEMBL120371 | 0.77 | HTR2A (0.49) | HTR2AMAPTALDH1A1KDM4EGAA | |
| SCHEMBL5827968 | 0.77 | HTR2A (0.80) | HTR2ABCL9CTNNB1ALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020065317-A1 | COLOUR FORMING COMPOSITIONS | DATALASE LTD. (GB) | 2020-04-02 | — | — | WO | disclosed |
| WO-2020065315-A1 | COLOUR FORMING COMPOSITION | DATALASE LTD. (GB) | 2020-04-02 | — | — | WO | disclosed |
| WO-2020065318-A1 | COLOUR FORMING COMPOSITION | DATALASE LTD. (GB) | 2020-04-02 | — | — | WO | disclosed |
| WO-2020065320-A1 | COLOUR FORMING COMPONENTS AND COMPOSITIONS | DATALASE LTD. (GB) | 2020-04-02 | — | — | WO | disclosed |
| WO-2020065321-A1 | COLOUR FORMING COMPOSITIONS | DATALASE LTD. (GB) | 2020-04-02 | — | — | WO | disclosed |
| US-9671396-B2 | Solid substrate comprising array of dendrons and methods for using the same | PARK JOON WON (KR) | 2017-06-06 | — | — | US | disclosed |
| US-9389227-B2 | Solid substrate comprising array of dendrons and methods for using the same | POSCO (KR) | 2016-07-12 | — | — | US | disclosed |
| US-9201067-B2 | Size-controlled macromolecule | POSCO (KR) | 2015-12-01 | — | — | US | disclosed |
| US-9175335-B2 | Biomolecule interaction using atomic force microscope | POSCO (KR) | 2015-11-03 | — | — | US | disclosed |
| US-8957212-B2 | Photobase generator | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2015-02-17 | — | — | US | disclosed |
| US-20080113353-A1 | Cantilevers with fixed end and free end modified by dendron | POSTECH FOUNDATION (KR) | 2008-05-15 | — | — | US | disclosed |
| EP-1920249-A2 | BIOMOLECULE INTERACTION USING ATOMIC FORCE MICROSCOPE | Pohang University of Science and Technology (KR) | 2008-05-14 | — | — | EP | disclosed |
| WO-2007135483-A2 | BIOMOLECULE INTERACTION USING ATOMIC FORCE MICROSCOPE | POHANG UNIVERSITY OF SCIENCE AND TECHNOLOGY (US) | 2007-11-29 | — | — | WO | disclosed |
| US-20070128623-A1 | Cantilevers with fixed end and free end modified by dendron | POSTECH FOUNDATION (KR) | 2007-06-07 | — | — | US | disclosed |
| WO-2006016787-A1 | CANTILEVER FOR ATOMIC FORCE MICROSCOPE, AND METHOD OF MEASURING BIOMOLECULE INTERACTION USING THE SAME | POSTECH FOUNDATION (KR) | 2006-02-16 | — | — | WO | disclosed |
| US-20050037413-A1 | functionalized substrates bound to layers of dendrimers and to target-specific ligands, used in combinatorial chemistry, protein, nucleic acid or nucleic acid/peptide hybridization detection; medical diagnosis | POSCO (KR) | 2005-02-17 | — | — | US | disclosed |
| EP-1170287-B1 | PROCESS FOR PREPARATION OF OPTICALLY ACTIVE N-SUBSTITUTED AZETIDINE-2-CARBOXYLIC ACIDS | KANEKA CORP (JP) | 2003-12-03 | — | — | EP | disclosed |
| US-6617461-B2 | Cyclizing an optically active 4-substituted amino-2-halobutyric acid containing substituted oxycarbonyl or sulfonyl type protective group in presence of a base | KANEKA CORPORATION (JP) | 2003-09-09 | — | — | US | disclosed |
| US-20030045730-A1 | Process for preparation of optically active n-substituted azetidine-2-carboxylic acids | KANEKA CORPORATION (JP) | 2003-03-06 | — | — | US | disclosed |
| EP-1170287-A1 | PROCESS FOR PREPARATION OF OPTICALLY ACTIVE N-SUBSTITUTED AZETIDINE-2-CARBOXYLIC ACIDS | KANEKA CORPORATION (JP) | 2002-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030045730-A1 | Process for preparation of optically active n-substituted azetidine-2-carboxylic acids | NISCH, ADCY9, ALAD | HTR2A 818/4885BCL9 1834/4885CTNNB1 4610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.